#SFHS2608160VNotice on Insurance Contribution Rates for Pharmaceutical Specialties
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The law sets the contribution rates for insured individuals for specific pharmaceutical products. Most drugs listed have a contribution rate of 35%, except for certain Fampiridine products, which have a rate of 85%. Healthcare providers and patients need to adjust their expectations for costs associated with these medications.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Set insured contribution rate to 35% for most drugs
- Fampiridine products have an 85% contribution rate
- Affects cost expectations for patients and providers
Obligations
What this law requires
Apply a 35% patient contribution rate to BRIVARACETAM ZENTIVA (all dosages: 25mg, 50mg, 75mg, 100mg) tablet presentations
Apply a 35% patient contribution rate to FUROSEMIDE TEVA SANTE 500mg tablets (CIP 34009 303 312 4 8)
Apply a 35% patient contribution rate to ZOLESTAD 5mg/100ml zoledronic acid infusion solutions (both borosilicate and silicon dioxide formulations)
Apply an 85% patient contribution rate to FAMPRIDINE SANDOZ LP 10mg extended-release tablets (both 28 and 56 tablet presentations)
Apply an 85% patient contribution rate to FAMPRIDINE ZENTIVA LP 10mg extended-release tablets (both 28 and 56 tablet presentations)